Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Dickson

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
F1000Research|September 6, 2016
Advances in gene therapy for muscular dystrophiesHayder Abdul-Razak, Alberto Malerba, George Dickson
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomersLinda J Popplewell, Alberto Malerba, George Dickson
Frontiers in Microbiology|April 6, 2016
Translational Inhibition of CTX-M Extended Spectrum β-Lactamase in Clinical Strains of Escherichia coli by Synthetic Antisense Oligonucleotides Partially Restores Sensitivity to CefotaximeJohn B Readman, George Dickson, Nick G Coldham
Nucleic Acid Therapeutics|January 13, 2017
Tetrahedral DNA Nanoparticle Vector for Intracellular Delivery of Targeted Peptide Nucleic Acid Antisense Agents to Restore Antibiotic Sensitivity in Cefotaxime-Resistant Escherichia coliJohn Benedict Readman, George Dickson, Nick G Coldham
Human Gene Therapy|April 11, 2015
Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophyPradeep Harish, Alberto Malerba, George Dickson, et al.
Human Gene Therapy|November 7, 2013
Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic miceTaeyoung Koo, Linda Popplewell, Takis Athanasopoulos, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2011
Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapyTakis Athanasopoulos, Helen Foster, Keith Foster, et al.
Expert Opinion on Biological Therapy|December 7, 2013
New developments in the use of gene therapy to treat Duchenne muscular dystrophySusan Jarmin, Hanna Kymalainen, Linda Popplewell, et al.
Methods in Molecular Medicine|January 16, 2003
Novel tools for production and purification of recombinant adeno-associated viral vectorsJulian D Harris, Stuart G Beattie, J George Dickson
Biomedicines|July 27, 2022
Long-Term Systemic Treatment of a Mouse Model Displaying Chronic FSHD-like Pathology with Antisense Therapeutics That Inhibit <i>DUX4</i> ExpressionNgoc Lu-Nguyen, George Dickson, Alberto Malerba, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
F1000Research|September 6, 2016
Advances in gene therapy for muscular dystrophiesHayder Abdul-Razak, Alberto Malerba, George Dickson
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomersLinda J Popplewell, Alberto Malerba, George Dickson
Frontiers in Microbiology|April 6, 2016
Translational Inhibition of CTX-M Extended Spectrum β-Lactamase in Clinical Strains of Escherichia coli by Synthetic Antisense Oligonucleotides Partially Restores Sensitivity to CefotaximeJohn B Readman, George Dickson, Nick G Coldham
Nucleic Acid Therapeutics|January 13, 2017
Tetrahedral DNA Nanoparticle Vector for Intracellular Delivery of Targeted Peptide Nucleic Acid Antisense Agents to Restore Antibiotic Sensitivity in Cefotaxime-Resistant Escherichia coliJohn Benedict Readman, George Dickson, Nick G Coldham
Human Gene Therapy|April 11, 2015
Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophyPradeep Harish, Alberto Malerba, George Dickson, et al.
Human Gene Therapy|November 7, 2013
Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic miceTaeyoung Koo, Linda Popplewell, Takis Athanasopoulos, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2011
Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapyTakis Athanasopoulos, Helen Foster, Keith Foster, et al.
Expert Opinion on Biological Therapy|December 7, 2013
New developments in the use of gene therapy to treat Duchenne muscular dystrophySusan Jarmin, Hanna Kymalainen, Linda Popplewell, et al.
Methods in Molecular Medicine|January 16, 2003
Novel tools for production and purification of recombinant adeno-associated viral vectorsJulian D Harris, Stuart G Beattie, J George Dickson
Biomedicines|July 27, 2022
Long-Term Systemic Treatment of a Mouse Model Displaying Chronic FSHD-like Pathology with Antisense Therapeutics That Inhibit <i>DUX4</i> ExpressionNgoc Lu-Nguyen, George Dickson, Alberto Malerba, et al.
Pageof 12